Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients
NCT00727883
·
clinicaltrials.gov ↗
COMPLETED
Status
190
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Sponsor
AstraZeneca